Abstract
Results of a cohort study suggest that use of buprenorphine during pregnancy leads to a reduced risk of adverse neonatal outcomes compared with methadone. There was no significant difference between buprenorphine and methadone in risk of adverse maternal outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
